K150476 is an FDA 510(k) clearance for the Spectra S1Plus and Spectra S2 Plus. Classified as Pump, Breast, Powered (product code HGX), Class II - Special Controls.
Submitted by Uzinmedicare Co. (Jungwon-Gu, KR). The FDA issued a Cleared decision on April 15, 2016 after a review of 416 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.5160 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Obstetrics & Gynecology submissions.
View all Uzinmedicare Co. devices